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METHODS
We performed a retrospective review of clinical cases.
Sac pressure measurements were performed in 21 patients
who had undergone stent graft repair of AAAs. Seventeen
(81%) of these had endoleaks demonstrated on computed
tomographic (CT) scans obtained 30 days after initial
implantation (Table). Access to the aneurysm sac in these
patients was through a direct translumbar sac puncture (5
patients), through a patent inferior mesenteric artery (IMA)
accessed via the superior mesenteric artery (SMA) (9
patients) or by direct cannulation around attachment sites
(3 patients). Pressure measurements in these 17 patients
were obtained as part of endoleak embolization procedures.
In these patients, pressures were sampled from within the
endoleak, not from the thrombosed portion of the
aneurysm sac. Endoleak pressures were recorded as “sys-
temic” if the mean pressure fell within approximately 20%
of the actual mean systemic pressure as measured through
an arterial catheter or brachial sphygmomanometer. The
remaining four patients (19%) had perioperative pressure
measurements obtained through catheters positioned along
side of the endovascular graft at the time of its deployment.
All patients were enrolled in one of several ongoing stent
graft clinical trials (Appendix) and signed an institutional
review board–approved informed consent.
Translumbar endoleak pressures. We have recently
described our technique for translumbar embolization of
Repair of abdominal aortic aneurysms (AAAs) by
means of endovascular grafting is thought to protect the
aneurysm sac from systemic pressure and thereby elimi-
nate the risk of rupture. The reaction of the aneurysm
sac after stent grafting, however, is unpredictable. Some
aneurysms shrink, some maintain their size, and others
will continue to enlarge.1,2 Many factors including the
presence or absence of endoleaks may contribute to this
variable reaction. Measuring pressures from within the
excluded aneurysm sac may help provide an explanation
for this inconsistent response. The purpose of our inves-
tigation was to evaluate the feasibility of various inter-
ventional techniques for measuring pressure within the
aneurysm sac in patients who had undergone endovas-
cular repair of AAAs.
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Objectives: The goal of endovascular grafting of abdominal aortic aneurysms (AAAs) is to exclude the aneurysm sac
from systemic pressure and thereby decrease the risk of rupture. Unlike conventional open surgery, branch vessels in
the sac (eg, lumbar artery and inferior mesenteric artery [IMA]) are not ligated and can potentially transmit pressure.
The purpose of our investigation was to evaluate the feasibility of various interventional techniques for measuring pres-
sure within the aneurysm sac in patients who had undergone endovascular repair of AAAs.
Methods: Sac pressure measurements were performed in 21 patients who had undergone stent graft repair of AAAs.
Seventeen of 21 patients had endoleaks demonstrated on 30-day computed tomographic (CT) scans. Access to the
aneurysm sac in these patients was through direct translumbar sac puncture (5 patients), through a patent IMA accessed
via the superior mesenteric artery (SMA) (9 patients), or by direct cannulation around attachment sites (3 patients).
Four patients had perioperative pressure measurements obtained through catheters positioned along side of the
endovascular graft at the time of its deployment. Two of these catheters were left in position for 30 hours during which
time CT and conventional angiography were performed. Pressures were determined with standard arterial-line pressure
transduction techniques and compared with systemic pressure in each patient.
Results: Elevated sac pressure was found in all patients. The sac pressure in patients with endoleaks was found to be
systemic (15 patients) or near systemic (2 patients) and all had pulsatile waveforms. Elevated sac pressures were also
found in patients without CT or angiographic evidence of endoleak (2 patients). Injection of the sacs in two of these
patients revealed a patent lumbar artery and an IMA.
Conclusions: It is possible to measure pressures from within the aneurysm sac in patients with stent grafts with a vari-
ety of techniques. Patients may continue to have pressurized AAA sacs despite endovascular AAA repair. Endoleaks
transmit pulsatile pressure into the aneurysm sac regardless of the type. It is possible to have systemic sac pressures
without evidence of endoleaks on CT or angiography. (J Vasc Surg 2001;33:32-41.)
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type 2 endoleaks.3 Direct translumbar endoleak punctures
were obtained with the patient prone on the fluoroscopy
table and under conscious sedation and local anesthesia.
The location of the leak was identified on CT and refer-
enced to bony landmarks and to the stent graft radiopaque
markers (Fig 1). A 19-gauge 20-cm needle with a 5F
Teflon sheath (Boston Scientific Corp, Watertown, Mass)
was advanced by means of fluoroscopic guidance through
the back at the level of the leak approximately 5 cm from
the midline. Once the aneurysm sac was entered, the inner
needle was removed, and the Teflon sheath was advanced
either alone or over a coaxial guidewire to reach the site of
leakage. Correct positioning within the endoleak was sig-
naled by a pulsatile return of blood through the 5F
catheter. Endoleak angiography was performed with an
injection of 10 to 20 mL of nonionic contrast
(Omnipaque 300; Nycomed, Inc, Princeton, NJ) to con-
firm the leak’s origin. Pressures were measured from
within in the leak with a pressure transducer (Mamic
Perceptor Morse Manifold, Medium Pressure; Boston
Scientific Corporation, NAMIC Technology Center, Glen
Falls, NY) placed at the level of the abdominal aorta and
compared with brachial sphygmomanometer pressure
readings. Endoleaks were then embolized to stasis with
microcoils.3 Postembolization pressures were also
obtained in these five patients from within the endoleak at
the completion of the procedure.
Transarterial pressure measurements. Cannulation
of the IMA in stent graft patients has previously been
described.4-6 With this technique, the IMA (and the
endoleak) can be entered by means of a coaxial micro-
catheter that travels a circuitous route from the SMA and
middle colic artery. In our series, aneurysm sac pressures
were obtained with a 3F 150-cm microcatheter (Fast
Tracker 18; Boston Scientific), which was positioned
within the endoleak. To achieve this, we placed a 4F or 5F
catheter into the proximal SMA through which a micro-
catheter was used to cannulate the middle colic artery and
IMA. The aneurysm sac was then entered in a retrograde
fashion, passing through the IMA. Intraendoleak pressure
measurements were recorded and compared with systemic
arterial pressure acquired simultaneously from the side
port of a 6F arterial sheath (Fig 2). Endoleaks were then
embolized to stasis with microcoils.4
Attachment site pressure measurements. Direct
cannulation of the aneurysm sac around attachment sites
was performed in the three patients who had type 1
endoleaks with 4F hydrophilic catheters (Glidecath;
Boston Scientific). This was accomplished from the right
common femoral artery in two patients and the left
brachial artery in one patient.
Intraoperative and perioperative pressure measure-
ments. Intraoperative and perioperative pressure measure-
ments were obtained in the aneurysm sacs of four patients
without evidence of endoleaks. In the first two patients,
microcatheters (Fast Tracker 18; Boston Scientific) were
positioned transarterially into the aneurysm sac during the
stent graft insertion procedure. Because of durability
issues, larger (4F) straight catheters (Glidecath; Boston
Scientific) were used in the final two patients. These
catheters were left in position for approximately 30 hours,
during which time CT and conventional angiography were
performed. Direct puncture of the femoral artery
(through the skin and subcutaneous tissue) was performed
with the Seldinger technique on the “contralateral side” to
introduce the catheters. In the three patients with modu-
lar bifurcated systems, this was done before the introduc-
tion and deployment of the contralateral limb. In the one
patient with a monoiliac graft, the pressure-measuring
catheter was introduced in the same fashion before con-
tralateral common iliac artery embolization. Patients were
followed up in an intensive care unit setting, and continu-
Endoleak pressure measurements in 17 patients
Patient Pressure Endoleak Arterial
no. Graft type Configuration Leak origin measured from: pressure pressure wave?
1 Talent Monoiliac IMA Transarterial Systemic Yes
2 Talent Monoiliac IMA Transarterial Systemic Yes
3 Talent Bifurcated IMA Transarterial Systemic Yes
4 Talent Bifurcated IMA Transarterial 1/2 systemic Yes
5 EVT Bifurcated PA PA Systemic Yes
6 EVT Bifurcated IMA Transarterial Systemic Yes
7 Talent Monoiliac IMA Translumbar Systemic Yes
8 Talent Bifurcated IMA Transarterial 1/2 systemic Yes
9 EVT Bifurcated IMA Transarterial Systemic Yes
10 Talent Monoiliac IMA Translumbar Systemic Yes
11 EVT Bifurcated IMA Translumbar Systemic Yes
12 Talent Bifurcated Lumbar Translumbar Systemic Yes
13 Talent Bifurcated Lumbar Translumbar Systemic Yes
14 Talent Bifurcated DA DA Systemic Yes
15 Talent Bifurcated PA PA Systemic Yes
16 Talent Monoiliac IMA Transarterial Systemic Yes
17 EVT Bifurcated IMA Transarterial Systemic Yes
DA, Distal attachment site; IMA, inferior mesenteric artery; PA, proximal attachment site.
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Fig 1. Systemic pressure in a lumbar endoleak through translumbar puncture. A, CT angiography in lower abdomen shows endoleak
(arrow) in right lateral portion of aneurysm sac. B, Direct translumbar catheterization (TLC) and angiography of the endoleak (E) show
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ous pressure monitoring was performed through the
intrasac catheter and compared with systemic arterial pres-
sure acquired simultaneously through a radial arterial line.
Prophylactic antibiotics (cefazolin, 1 g; American Pharma-
ceutical Partners, Inc, Los Angeles, Calif) were given
intravenously at the time of the procedure and continued
while the catheter was in place.
Two patients with indwelling sac catheters underwent
CT scans at 30 hours, which were followed by contrast
angiograms performed with a 10-cc injection of iodinated
contrast (Omnipaque 300; Nycomed, Inc) into the
aneurysm sac. In one patient, the catheter was also with-
drawn from the sac into the native external iliac artery and
was then advanced into the lumen of the stent graft where
a pigtail aortogram was performed.
RESULTS
Intra-aneurysm sac pressure measurements were suc-
cessfully acquired in each of the 21 patients studied. There
were no failed sac pressure measurement attempts.
Elevated pressures and arterial waveforms were found in
every one of the 17 patients with endoleaks, 15 (88%) of
which were systemic. The remaining two patients (12%)
had pressures that were one-half systemic (Table). The ori-
gin of the endoleaks was from the IMA in 12 patients, the
lumbar arteries in 2 patients, the proximal attachment site
in 2 patients, and the distal attachment site in 1 patient.
There was no distinction between the type and size of the
endoleak and the pressure measurement obtained.
Translumbar access to the aneurysm sac and endoleaks
was achieved successfully in all five patients studied. There
were no complications related to the procedure, and all
patients were discharged home the following morning.
Preembolization endoleak pressures were systemic with
arterial waveforms in all five patients and fell to between
20 and 30 mm Hg after treatment (Fig 3).
Fig 2. Systemic pressure in IMA endoleak. A, A transarterial catheter (arrow) is placed through the IMA and into an endoleak (E) via
the SMA. B, Systemic pressure is measured from within IMA endoleak. IMA, Inferior mesenteric artery.
A
B
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Fig 3. Translumbar embolization of a lumbar endoleak. A, Translumbar endoleak angiogram through a 5F catheter (TLC) in the antero-
posterior projection. B, Systemic pressure is measured from within IMA endoleak. C, The endoleak pressure falls to 25 mm Hg after
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Transarterial pressure measurements were successfully
obtained through a microcatheter in nine patients with
IMA endoleaks and were compared with femoral arterial
pressure. The endoleak pressures were systemic with an
arterial pressure wave in seven (78%) of nine patients (Fig
2). Two patients had pressure that was one-half systemic
with arterial waveforms.
Intraendoleak pressures were also successfully measured
in three patients with attachment site leaks and compared
with femoral arterial pressure. The endoleaks contained sys-
Fig 4. Type 1 endoleak angiogram. A, Contrast angiography in the anteroposterior projection shows type 1 endoleak (E). B, Angiogram
from within endoleak shows a draining lumbar artery (LA).
A
B
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temic pressure with arterial waveforms as measured with a
5F catheter positioned from within the leak (Fig 4).
Elevated sac pressure was also found in the four
patients without CT or angiographic evidence of
endoleak. Initially, the mean and pulse pressures fell in
three patients as soon as the aneurysm was excluded. In
the fourth patient (with a monoiliac graft), the pressure
did not fall after aneurysm exclusion and contralateral
common iliac artery embolization. The 3F microcatheters
that were placed in two of these patients were not durable.
The first did not function after the patient was transferred
to the recovery room, and the second failed after the
patient sat up in bed 3 hours after the procedure. Both
catheters were removed at bedside without complication.
Placement of the 4F catheters proved sturdier with each
functioning well until they were removed 30 hours after
placement. The sac pressure in these two patients contin-
ued to rise during the perioperative period and became
systemic at approximately 24 hours. Injection of the sacs
in these two patients revealed a patent lumbar artery and
an IMA despite negative results from CT and conventional
angiograms (Fig 5).
DISCUSSION
The response of an AAA to endovascular grafting is
unpredictable.2,7-9 Even if an aneurysm is successfully
excluded, there is no guarantee that the sac will shrink.
Guidant/EVT reports that only 68.5% of patients from its
US clinical trial had shrinking aneurysms at 2 years.10 The
implication of an endograft patient with a nonshrinking
aneurysm is a topic of great debate.
Intraendoleak pressure measurements. We are
unaware of other reports of in vivo pressure measurements
taken from within endoleaks. Many have suggested that
endoleaks pressurize the aneurysm sac and put the patient
at risk for rupture.11 Clever animal and human models have
supported this assertion.12-14 Our finding of systemic pres-
sure and arterial waveforms from within endoleaks validates
this principle. All endoleaks in our study had arterial wave-
forms and elevated pressure with 15 (88%) of 17 being sys-
temic. The significance of the two patients with endoleaks
who had one-half systemic pressure is uncertain. It is possi-
ble that these endoleaks represent less well-developed
IMA–lumbar artery circuits. It is also possible that the
severe tortuosity kinked the 3F microcatheter and led to
inaccurate pressure transduction because this finding was
not seen when endoleaks were entered with 5F translumbar
or transarterial catheters.
The most straightforward, robust, and our preferred
method for measuring aneurysm sac pressures was by
direct translumbar puncture. This easily enabled us to
position large (5F) catheters directly within endoleaks.
Not only were pressures able to be measured directly, but
this technique also allowed us to perform endoleak
angiography and assess the results of embolization. In our
series, all five translumbar patients had postembolization
pressures of less than 30 mm Hg. Although this represents
a dramatic reduction, we were never able to reduce the
pressure in the leak to less than 20 mg Hg despite packing
the leaks tightly with coils. Perhaps this residual pressure
represents transmitted pressure from surrounding struc-
tures and a “diaphragm effect” the pulsatile graft has on
the surrounding aneurysm sac.
When to treat endoleaks. When to intervene in a
patient with an endoleak is a complex and controversial
question. Some think that it is important to treat attach-
Fig 5. Intra-aneurysm sac injection after endovascular repair of AAA (L). Contast injection through a 5F intrasac catheter 30 hours after
uniiliac stent graft repair of AAA shows multiple patent lumbar arteries. Systemic pressure was measured from within the sac (S). The
patient had a negative result from CT scan 30 minutes before angiogram.
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ment site leaks early while acceptable to wait for collateral
leaks to thrombose spontaneously.15,16 Because we could
demonstrate systemic pressure in both attachment and
collateral leaks regardless of their size or type (IMA or
lumbar artery), we have adopted a more aggressive
approach. At our institution, if a patient demonstrates a
leak on the 30-day CT scan, it is treated. We realize that
some collateral endoleaks will spontaneously thrombose;
however, until that occurs we have shown that there is sys-
temic arterial pressure within the aneurysm sac. It is
unknown whether an embolized endoleak differs in phys-
iology or long-term outcome from a spontaneously
thrombosed leak.17 We are, however, encouraged that we
were able to decrease endoleak pressures after emboliza-
tion to less than 30 mm Hg in all five translumbar cases
(Fig 3). It would be interesting to measure sac pressures
in patients who have undergone either treatment or spon-
taneous closure of their endoleaks.
Intrasac pressure measurements. The concept of
cannulating the backside of a stent graft to measure pres-
sures is not a new one.18 In 1997, Chuter et al19 placed
catheters alongside eight aorto-uniiliac stent grafts.19
They found a significant decrease in both mean and pulse
pressures when compared with radial artery pressure. Our
limited experience in four patients using essentially the
same technique confirms their findings. Immediately after
aneurysm exclusion there was a reduction in mean and
pulse pressures in the sac of each bifurcated patient (3
patients). Unlike Chuter et al, however, we left the
catheters in position (in 2 patients) during the periopera-
tive period and found that mean and pulse pressure con-
tinued to rise the longer the catheter was left in place; at
times, it exceeded the radial artery mean pressure. The
exact significance of this finding is uncertain, but perhaps
the reversal of branch vessel flow and the establishment of
ingress and egress channels through the clotted sac take
time to develop. It would be unwise to make any conclu-
sions on the basis of only two patients.
A potential limitation of this technique is the possibil-
ity of creating an attachment site endoleak with the pres-
sure-measuring catheter. However, we think that this is
unlikely to occur because of the small size of the catheter
and the length the catheter travels behind the supported
stent graft limbs.
Endotension. The concept of pressurized sacs and
occult endoleaks that are not visualized with current imag-
ing has recently been introduced, and the term endoten-
sion has been applied.20,21 Our series shows that this
concept is possible because two patients had systemic pres-
sures within the aneurysm sac 30 hours after endograft
repair without CT or angiographic evidence of endoleaks
(Fig 5). Our findings also demonstrate the potential limi-
tations of CT angiography in visualizing all endoleaks.
Limitations. Our investigation is limited in scope
because of its small sample size and retrospective design. A
prospective longitudinal study in which intrasac pressures
are measured in patients with and without endoleaks
would be useful. This would be possible by modifying our
existing translumbar embolization technique3 to use a 21-
gauge needle (rather than a 5F catheter). Pressure mea-
surements could be obtained every 6 months for the life of
the graft or until the aneurysm sac disappeared. This pro-
cedure could also be used to investigate aneurysm sacs in
patients whose aneurysms have failed to shrink despite the
absence of endoleaks on CT angiography. Performing
translumbar intrasac angiography in these patients could
determine the etiology of occult endoleaks.
Another potential limitation is the lack of true sac
pressure measurements in the endoleak group. In these
patients, pressures were obtained from the endoleak itself,
which may be different from the pressure in the sur-
rounding thrombus-filled sac. It would be interesting to
measure pressures from within the thrombus-filled sac and
endoleak simultaneously before, during, and after endoleak
embolization.
Summary. In conclusion, our feasibility study shows that
it is possible to measure pressures from within the aneurysm
sac in patients with stent grafts with a variety of techniques.
By doing this we have made several observations: 
1. Patients may continue to have pressurized AAA 
sacs despite endovascular AAA repair.
2. Endoleaks transmit pulsatile pressure into the 
aneurysm sac regardless of type, and in most 
cases this pressure is systemic.
3. It is possible to have systemic sac pressures with-
out evidence of endoleaks on CT or angiography.
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APPENDIX
Clinical trials
1. A phase II investigation of the TALENT endoluminal
spring stent-graft system for the treatment of subrenal
abdominal aortic aneurysms in patients who are not
candidates for standard surgical intervention.
2. A phase II investigation of the TALENT endoluminal
spring stent-graft system for the treatment of subrenal
abdominal aortic aneurysms in patients who are can-
didates for standard surgical intervention.
3. Use of the TALENT endoluminal spring stent-graft
system in high–surgical risk patients with abdominal
aortic aneurysm—emergency/compassionate use pro-
tocol.
4. A phase II clinical study of the aortoiliac EGS system
as compared with the standard surgical procedure in
the treatment of abdominal aortic aneurysms.
5. A phase III clinical study of the safety and efficacy of
EVT Ancure tube and bifurcated systems.
DISCUSSION
Dr Sachinder S. Hans (Warren, Mich). I have one question
and one observation. The observation is that we measured the
aneurysm sac pressure in 21 patients during open abdominal
aneurysm resection by proximal clamping of the aortic neck and
distal clamping of the iliac arteries, and we found out that the
aneurysm sac pressure was slightly less than half of the mean sys-
temic blood pressure. Obviously, we always took the ratio of the
aneurysm sac pressure to the mean blood pressure of the patient,
and we calculated that ratio and it was slightly less than half. Not
surprisingly, it directly correlated with the number of actively
bleeding lumbar arteries. It had no relationship to the size of the
aneurysm or the presence of the thrombus in the aneurysm. 
I have one question regarding your study: you had four or
five different techniques of measuring the aneurysm sac pressure.
Are these techniques equally sensitive? Have you tested them in
the animal or the lab model?
And the follow-up question I have is, that these two aneurysm
sac pressures, the one that you describe and the one we have mea-
sured in the aneurysm sac during open aneurysm resection, are not
the same. It appears that aneurysm sac pressure even increases in
the follow-up period after the implantation of the device.
Thank you very much, Dr Baum, for an excellent presentation.
Dr Richard A. Baum. In terms of our techniques, no, we have
not tested them in the laboratory or in an animal model. You have
to remember that this particular study was a retrospective look at
clinical cases. The pressure measurements were obtained during
treatment for endoleaks, and as our techniques evolved over time,
we measured pressures in different ways. Our algorithm now is
certainly a lot different than it was 2 years ago.
Your second point is correct. In our limited experience we have
seen aneurysm sac pressures during the first 24 hours after insertion.
Dr John D. Edwards (Cincinnati, Ohio). What a beautiful
paper and beautiful demonstration. I’ll paraphrase Dr Green; I
hope I do it well. At a meeting in Boston I heard him speak at a
couple of years ago, he asked if we can replace an effective treat-
ment that essentially cures patients of their disease with a prophy-
lactic procedure? He said it more eloquently, but I think you sort
of showed why that was. I hope that was okay, Dr Green.
Now to my question. This should surprise the radiologists
who would pretend to be aneurysm experts and should maybe
educate the cardiologists, but we’ve all been in a situation where
we’ve fixed the aneurysm. There weren’t any lumbar back bleed-
ers, but we were pretty sure our resident must have missed a cou-
ple. We didn’t see any, and after reperfusing direct flow to the
hypogastrics and the externals and all those collaterals, they
started to bleed after the fact, and maybe even sometimes, unfor-
tunately, brought us back to the operating room in the middle of
the night. So this probably shouldn’t be surprising. 
Now, to my question. Dr Parodi, who stays ahead of this curve
and amazes me still, for 2 years has been talking about clipping
laparoscopic approaches. Is that what you’re going to do at HUP
now because of all this, or are you going to change your approach
and combine a laparoscopic with an endoluminal approach? 
Dr Baum. Thank you for your kind comments. With regard to
your question, yes, I was surprised by our findings, but I am a
radiologist.
Dr Edwards. A radiologist at a surgical meeting, though. 
Dr Baum. There you go.
We have not attempted laparoscopic repair of collateral
endoleaks at our hospital largely because we have been able to
treat them using transarterial or translumbar techniques. 
Dr Berguer. Dr Green, do you want to make a correction? 
Dr Green. John, it was palliative. We’ve taken a cure and given
a palliation.
Dr Edwards. What did I say? Prophylactic. You know, you’ve
got to learn English.
May I rise to ask one more question? 
Dr Baum. Sure.
Dr Edwards. What’s the difference between thrombus that
God and the aneurysm sac put there and thrombus that you put
there when you embolize a vessel that’s back bleeding? Why is the
one protective and the other is not? 
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Dr Baum. I think what we’re doing by embolization is putting
up a dam or blocking flow through the aneurysm sac. And you’re
absolutely right, I’m not certain that my embolization techniques
are any more or less effective than just a clot in the aneurysm sac.
I think it would be very interesting to measure pressures within
aneurysm sacs in both patients with and without endoleaks to
learn if there is a difference. 
Dr Takao Ohki (New York, NY). I have two questions. One
is a very quick one.
At what period did you intervene on these 17 endoleaks?
That’s question one. Can I have the answer for that first? 
Dr Baum. We treated our endoleaks from 30 days to 6 months
after stent graft deployment. 
Dr Ohki. So I think you are intervening on these type 2
endoleaks a bit too early. If you could wait a bit longer, they might
thrombose spontaneously. This is my number one comment.
Number two is regarding your comment about no matter
what the size, where they came from, they all exerted systemic pres-
sure. I think that observation is correct, but the message that obser-
vation sends out I think needs some careful interpretation. You
showed one type 1 endoleak from the proximal attachment site,
and you showed several type 2 from the lumbar or the IMA. In
terms of the pressure measurements, they were the same. But in
terms of the treatment options and the outcome, they are totally
different. If you embolize the type 2 systemic pressure leaks, they
are fine. But if you try to do the same thing with a type 1, they are
basically untreated. And I think you have to differentiate the source
of the leak regardless of the fact that they were the same pressure.
Dr Baum. I think that’s conventional wisdom, but I’m not sure
it’s correct. From our preliminary work we have shown that there is
little difference in sac pressure in patients with type 1 and type 2
endoleaks. In terms of why we intervene so soon, you have to
remember, we now have a straightforward procedure (translumbar
endoleak embolization), which can be done in these patients. You
can wait for the endoleaks to thrombose on their own, and I realize
if you look at the data and other people’s experience, a lot of these
type 2 endoleaks will seal. But I think the thing you can learn from
our experience is that until they do seal, they have systemic pressure.
And if you have an aneurysm with a systemic pressure and you have
an easy way to fix it, why wait? You’ve done all of the detail work to
measure it, to design the graft, to put the graft in. Why not, with
very little morbidity, just finish the procedure? Do the best you can. 
Dr Ohki. Then why not use embolization agent at the time of
the procedure? 
Dr Baum. You’re exactly right: embolization of the aneur-
ysm sac after stent graft deployment could prevent type 2 leaks
from forming. 
Dr Ohki. And we do have a paper at the upcoming European
vascular society proving that not all endoleaks are the same after
thrombosis.
Dr Mark A. Mattos (Springfield, Ill). One just sort of
research, philosophical question. Dr Baum, do you think there is
a role for the possibility that when you place the graft primarily or
possibly putting either thrombin or an acrylic compound to seal
any of those endoleaks by leaving a catheter in one of the limbs
and, as you seal that ipsilateral limb, pulling it out, therefore
avoiding systemic injection of that, but certainly sealing the
aneurysm at the time of surgery? 
Dr Baum. That’s obviously the answer to all of this, some sort
of insulation material, if you will, foam or something that goes in
at the time of stent graft deployment. I think thrombin is proba-
bly not the right choice because its effects are at the capillary
level, but something that sticks in the arteriole level. You’re
absolutely right; I think that is an obvious solution.
Dr Geoffrey H. White (Sydney, Australia). I would also like
to congratulate you for a superb paper and for confirming what
we suspected about pressure in these type 2 endoleaks. We know
the effects of type 2 endoleak and type 1 are markedly different,
presumably because their pressure isn’t transmitted as readily
through the thrombus or because the flow is lower. I’m wonder-
ing if you had the opportunity to measure pressure within the
thrombus adjacent to the endoleak cavity and also whether you
found any difference between using coils alone or coils plus
adjuncts, such as fibrin glues? 
Dr Baum. Thank you for your comments. Yes, we have been
able to measure clot pressure translumbar embolization. You
don’t always get directly into the endoleak at the time of
translumbar puncture. Sometimes you have to meander around
the sac a little bit to find the actual leak site. In these patients we
measured systemic pressures from within the sac thrombus itself.
Again, what I think really needs to be done is to apply our
translumbar technique, to measure pressures before or after dif-
ferent treatments and in patients without endoleaks. I mean we
don’t know what the pressure is in an aneurysm that is shrinking.
Maybe that has systemic pressure. 
Dr White. The pressure in the thrombus next to the cavity, is
that elevated as well? 
Dr Baum. Yes, it is, before we embolize the leak, and it falls
when the leak is treated with embolization. 
Dr Juan C. Parodi (Buenos Aires, Argentina). I want to con-
gratulate you for your superb presentation. I think this is a very
important issue. As a matter of fact, I think this is the problem we
still have to solve. The other is neck dilatation, which I don’t
believe is an issue anymore, since we are learning that placing the
proximal end of the endograft close to the renal arteries or even
crossing them provides secure fixation and sealing, and at last the
industry is going to take care of mechanical failures of devices that
we have seen with several systems.
We tried many years ago to occlude the sac at the same time
we were placing the endograft. And even doing angioscopy of the
sac, it was not very easy at all to identify and occlude the
branches. We ended up injecting Spongostan free in the sac. And
I am aware of a study, long term now, from Nottingham, they
injected Spongostan in the sac during the procedure having
superb results. They had just 4% of type 2 endoleaks after 3 years
in patients that had more than 4 lumbars to start with. So they
were able to occlude 96% of them during the procedure. They are
now using Ivalon instead of Spongostan. Dr Hopkinson has many
more cases than we have. We believe that this is going to be a
good approach.
My question is: Are you planning to start doing this during
the procedure to prevent these type 2 endoleaks? 
Dr Baum. Thank you for your remarks and insightful comments.
We have not tried to use materials that would help thrombose
branch vessels at the time of stent graft deployment. In addition to
regulatory issues, we have not identified the ideal embolic agent.
